Search SEC
Fundamental Analysis
16 matches · 10756 cached companies
| Company | Fundamental | Momentum | Acceleration | Confidence | Revenue Growth | ROIC | FCF Growth | Op Margin Delta | Share Growth | Dividend Yield | Dividend Years | Payout Ratio | P/E | Signals |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ONCBeOne Medicines Ltd. | 89.9 | 100 | 100 | 91 | +56.49% | +26.09% | n/a | +195.04% | +4.16% | 0% | 0 | n/a | n/a | Gross margin expansion, Operating leverage, ROIC expansion, Net debt reduction |
| CLEVConcrete Leveling Systems Inc | 60.3 | 100 | 100 | 85 | +9,525.21% | n/a | n/a | +5,137.69% | 0% | 0% | 0 | n/a | n/a | Gross margin expansion, Operating leverage, Net debt reduction |
| CONConcentra Group Holdings Parent, Inc. | 67.6 | 51.6 | 51.6 | 69 | +18.76% | +95.01% | n/a | n/a | -0.28% | 0.71% | 3 | 19.28% | n/a | Operating leverage, Net debt reduction, Share count reduction, Strong operating leverage |
| DFPHStarling Oncology, Inc. | 50.9 | 96.2 | 97.7 | 75 | +42.14% | -51.74% | n/a | +12.98% | +33.64% | 0% | 0 | n/a | n/a | Operating leverage, ROIC expansion, Net debt reduction2 warnings |
| STLNStarling Oncology, Inc. | 50.9 | 96.2 | 97.7 | 75 | +42.14% | -51.74% | n/a | +12.98% | +33.64% | 0% | 0 | n/a | n/a | Operating leverage, ROIC expansion, Net debt reduction2 warnings |
| STLNWStarling Oncology, Inc. | 50.9 | 96.2 | 97.7 | 75 | +42.14% | -51.74% | n/a | +12.98% | +33.64% | 0% | 0 | n/a | n/a | Operating leverage, ROIC expansion, Net debt reduction2 warnings |
| TOIStarling Oncology, Inc. | 50.9 | 96.2 | 97.7 | 75 | +42.14% | -51.74% | n/a | +12.98% | +33.64% | 0% | 0 | n/a | n/a | Operating leverage, ROIC expansion, Net debt reduction2 warnings |
| TOIIWStarling Oncology, Inc. | 50.9 | 96.2 | 97.7 | 75 | +42.14% | -51.74% | n/a | +12.98% | +33.64% | 0% | 0 | n/a | n/a | Operating leverage, ROIC expansion, Net debt reduction2 warnings |
| CRDFCardiff Oncology, Inc. | 39.4 | 0 | 0 | 89 | -39.88% | -1,095.85% | n/a | -1,651.83% | +2.82% | 0% | 0 | n/a | n/a | n/a2 warnings |
| BBCPConcrete Pumping Holdings, Inc. | 30.8 | 43.7 | 44.9 | 100 | +3.8% | +4.51% | -66.47% | -2.26% | -3.03% | 1.32% | 2 | 833.7% | 57.64x | Net debt reduction, Share count reduction2 warnings |
| TMCITREACE MEDICAL CONCEPTS, INC. | 31.9 | 63.6 | 77 | 83 | -1.58% | -58.76% | n/a | -4.9% | +3.81% | 0% | 0 | n/a | n/a | Operating leverage, ROIC expansion1 warning |
| CNXCConcentrix Corp | 29.1 | 43.3 | 43.3 | 85 | +3.36% | +5.38% | n/a | -4.98% | -5% | 5.78% | 6 | n/a | 7.32x | Net debt reduction, Share count reduction |
| GBRNew Concept Energy, Inc. | 27.8 | 12.9 | 26.5 | 83 | +7.43% | -5.24% | n/a | -95.96% | n/a | 0% | 0 | n/a | n/a | n/a1 warning |
| CHRSCoherus Oncology, Inc. | 28.9 | n/a | n/a | 62 | n/a | n/a | n/a | n/a | n/a | 0% | 0 | n/a | n/a | Net debt reduction |
| CSBRCHAMPIONS ONCOLOGY, INC. | 22.7 | 1.6 | 1.6 | 79 | +6.81% | n/a | n/a | -3.23% | n/a | 0% | 0 | n/a | n/a | Net debt reduction2 warnings |
| OTLCOncotelic Therapeutics, Inc. | 24 | 0 | 0 | 71 | -82.57% | -3.26% | n/a | n/a | +393.91% | 0% | 0 | n/a | n/a | n/a2 warnings |
1-16 of 16